The Quantellect read.As of Nov 19, 2026, 5 active firms cover Pulse Biosciences Inc: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $58.00 to $73.00, so the covering firms are broadly aligned. The average target of $63.80 sits 39% above the current $45.79. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.29 next quarter toward $-1.16 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$63.80
+39.3% upside
Average target across 5 active firms as of Nov 19, 2026 vs $45.79 current
Highest Target$73.00
Average Target$63.80
Lowest Target$58.00
Detailed analyst forecasts for PLSE
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate PLSE a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PLSE EPS & revenue forecast
EPS · NEXT QUARTER
$-0.29
Range $-0.31 – $-0.27 · 2 analysts · +20% YoY
Next period, 2 analysts expect Pulse Biosciences Inc to earn $-0.29 a share (range $-0.31 – $-0.27), versus $-0.24 a year earlier. Full-year consensus is $-1.05, growing to $-1.16 the year after.
REVENUE · NEXT QUARTER
$743.3K
Range $400.0K – $1.0M · 2 analysts · +85% YoY
Revenue is expected to reach $743.3K (range $400.0K – $1.0M), +85.4% year-over-year. Full-year consensus is $1.8M, rising to $4.6M next year.
Top analysts covering Pulse Biosciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PLSE.
#1
Anthony Petrone
Mizuho · Rank #121
Buy
$45.00-1.7% to target
Overall win rate
45%
+ Follow
#2
Mike Matson
Needham · Rank #285
Buy
$58.00+26.7% to target
Overall win rate
36%
+ Follow
#3
William Plovanic
Canaccord Genuity · Rank #370
Buy
$58.00+26.7% to target
Overall win rate
38%
+ Follow
#4
Suraj Kalia
Oppenheimer
Buy
$60.00+31.0% to target
Coverage
—
+ Follow
#5
KH
Keith Hinton
Freedom Capital Markets
Buy
$73.00+59.4% to target
Coverage
—
+ Follow
PLSE stock forecast FAQ
What is PLSE's average 12-month price target?+
The 5 active firms with a live target average $63.80 for Pulse Biosciences Inc over the next 12 months, ranging from a $73.00 high to a $58.00 low, as of Nov 19, 2026.
Is PLSE stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for PLSE?+
The Street-high target is $73.00 (Freedom Capital Markets), and the Street-low is $58.00 (Canaccord Genuity). The average of all 5 active-firm targets is $63.80.
How many active Wall Street firms cover PLSE?+
5 active firms have a recognized rating on Pulse Biosciences Inc as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PLSE?+
Among analysts who currently cover PLSE, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #121). Their current call is Buy with a $45.00 target.
What is Pulse Biosciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.29 per share (range $-0.31 – $-0.27) across 2 analysts. Full-year EPS is projected at $-1.05, rising to $-1.16 the following year.
How much revenue is Pulse Biosciences Inc expected to report next quarter?+
Consensus revenue is $743.3K (range $400.0K – $1.0M). Full-year revenue is projected at $1.8M, growing to $4.6M next year.
Have analysts been upgrading or downgrading PLSE lately?+
As of Nov 19, 2026, 5 of 5 active firms rate PLSE a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PLSE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.